Featured Research

from universities, journals, and other organizations

Novel Pandemic Flu Vaccine Effective Against H5N1 In Mice

Date:
March 6, 2009
Source:
Emory University
Summary:
Virus-like particles offer a chicken egg-free method of producing influenza vaccines. Immunization with virus-like particles effectively protects mice from H5N1 influenza and could be an attractive mode of vaccination in humans.

Vaccines against H5N1 influenza will be critical in countering a possible future pandemic. Yet public health experts agree that the current method of growing seasonal influenza vaccines in chicken eggs is slow and inefficient.

Related Articles


Scientists at the Emory Vaccine Center have developed an alternative: virus-like particles, empty shells that look like viruses but don't replicate. Mice immunized by nose drops with the virus-like particles (VLPs) were protected for months against an otherwise lethal H5N1 infection.

"These results suggest that VLPs could form the basis of an effective human vaccine against H5N1 influenza," says senior author Richard Compans, PhD, professor of microbiology and immunology at Emory University School of Medicine.

Several worldwide influenza outbreaks have occurred during the past century, with the worst being the Spanish Flu of 1918, which killed more than 50 million people.

The H5N1 variant of influenza, found among birds in Asia in the 1990s, has killed the majority of the several hundred people known to have been infected with it. Public health officials fear that H5N1, to which the human population has not developed immunity, could evolve to be transmissible between humans and cause a global pandemic with very high mortality.

Making influenza vaccines in chicken eggs poses several disadvantages. Producing vaccines takes months. Making enough for millions of people could severely stress the world's vaccine-making capacity, especially since the poultry industry would probably be crippled in a pandemic. In addition, work with live H5N1 virus is dangerous and should only be performed in special laboratories.

As an alternative to live influenza viruses, VLPs are made by introducing three separate viral genes into baculoviruses, which only infect insect cells. Baculovirus-infected insect cells are then grown in culture, in a similar fashion to bacteria or yeast, and produce the VLPs. The VLPs appear to have a structure like influenza viruses under an electron microscope but lack the ability to replicate or to cause influenza.

Compans and first author Sang-Moo Kang, PhD, Emory assistant professor of microbiology and immunology, demonstrated the ability of VLPs to stimulate antibody production in mice. In collaboration with a team at the Centers for Disease Control and Prevention led by Ruben Donis, PhD, they showed that the mice immunized with VLPs could resist an otherwise lethal dose of H5N1 virus isolated from Vietnam.

The mice's immunity, including the levels of antibodies that protected their respiratory systems, stayed stable for over six months.

In mice, VLPs appear to deliver several times more potency per microgram than other types of vaccines, such as the chemically inactivated subunit viral vaccine currently used in the United States or a single viral protein produced in baculovirus.

"This extra potency is important because the current egg-grown vaccines require relatively high doses to be effective for most people, and in a pandemic demand might run up against production capacity. VLPs could offer more bang for the buck," Compans says.

Some next steps in the development of the vaccine are to find out if it can also protect against infection by mutant forms of the virus that arise frequently in birds, he says. Also, the vaccine will be evaluated in other animal species, in which influenza causes disease symptoms similar to those seen in humans.

The research was supported by the National Institutes of Health and the Korean Ginseng Society.


Story Source:

The above story is based on materials provided by Emory University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Kang et al. Induction of Long-Term Protective Immune Responses by Influenza H5N1 Virus-Like Particles. PLoS ONE, 2009; 4 (3): e4667 DOI: 10.1371/journal.pone.0004667

Cite This Page:

Emory University. "Novel Pandemic Flu Vaccine Effective Against H5N1 In Mice." ScienceDaily. ScienceDaily, 6 March 2009. <www.sciencedaily.com/releases/2009/02/090228075736.htm>.
Emory University. (2009, March 6). Novel Pandemic Flu Vaccine Effective Against H5N1 In Mice. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2009/02/090228075736.htm
Emory University. "Novel Pandemic Flu Vaccine Effective Against H5N1 In Mice." ScienceDaily. www.sciencedaily.com/releases/2009/02/090228075736.htm (accessed October 31, 2014).

Share This



More Plants & Animals News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Watch Baby Goose Survive A 400-Foot Cliff Dive

Watch Baby Goose Survive A 400-Foot Cliff Dive

Buzz60 (Oct. 31, 2014) For its nature series Life Story, the BBC profiled the barnacle goose, whose chicks must make a daredevil 400-foot cliff dive from their nests to find food. Jen Markham has the astonishing video. Video provided by Buzz60
Powered by NewsLook.com
World's Salamanders At Risk From Flesh-Eating Fungus

World's Salamanders At Risk From Flesh-Eating Fungus

Newsy (Oct. 31, 2014) The import of salamanders around the globe is thought to be contributing to the spread of a deadly fungus. Video provided by Newsy
Powered by NewsLook.com
Alcoholic Drinks In The E.U. Could Get Calorie Labels

Alcoholic Drinks In The E.U. Could Get Calorie Labels

Newsy (Oct. 31, 2014) A health group in the United Kingdom has called for mandatory calorie labels on alcoholic beverages in the European Union. Video provided by Newsy
Powered by NewsLook.com
Malaria Threat in Liberia as Fight Against Ebola Rages

Malaria Threat in Liberia as Fight Against Ebola Rages

AFP (Oct. 31, 2014) Focus on treating the Ebola epidemic in Liberia means that treatment for malaria, itself a killer, is hard to come by. MSF are now undertaking the mass distribution of antimalarials in Monrovia. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Plants & Animals

Earth & Climate

Fossils & Ruins

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins